BridgeBio Pharma Historical PE Ratio image   This BBIO PE ratio history page last updated 4/23/2024
BridgeBio Pharma Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/22/2024
33.60-0.96-3.84NA
Q3 2023
11/2/2023
26.92-1.08-4.32NA
Q2 2023
8/3/2023
32.10-0.98-3.92NA
Q1 2023
5/4/2023
13.50-0.92-3.68NA
Q4 2022
2/23/2023
11.67-0.92-3.68NA
Q3 2022
11/3/2022
9.86-0.93-3.72NA
Q2 2022
8/4/2022
9.98-0.81-3.24NA
Q1 2022
5/5/2022
7.51-1.19-4.76NA
Q4 2021
2/24/2022
8.00-1.01-4.04NA
Q3 2021
11/4/2021
51.46-1.06-4.24NA
Q2 2021
8/5/2021
56.13-0.66-2.64NA
Q1 2021
5/6/2021
49.59-1.18-4.72NA
Q4 2020
2/25/2021
65.13-1.01-4.04NA
Q3 2020
11/5/2020
40.99-0.98-3.92NA
Q2 2020
8/11/2020
28.39-1.03-4.12NA
Q1 2020
5/13/2020
30.78-0.78-3.12NA
Q4 2019
3/2/2020
32.21-0.62-2.48NA
Q3 2019
11/7/2019
24.42-0.51-2.04NA
Q2 2019
8/14/2019
25.89-3.46-13.84NA
BridgeBio Pharma PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/22/2024
33.60-0.96-3.94NA
Q3 2023
11/2/2023
26.92-1.08-3.90NA
Q2 2023
8/3/2023
32.10-0.98-3.75NA
Q1 2023
5/4/2023
13.50-0.92-3.58NA
Q4 2022
2/23/2023
11.67-0.92-3.85NA
Q3 2022
11/3/2022
9.86-0.93-3.94NA
Q2 2022
8/4/2022
9.98-0.81-4.07NA
Q1 2022
5/5/2022
7.51-1.19-3.92NA
Q4 2021
2/24/2022
8.00-1.01-3.91NA
Q3 2021
11/4/2021
51.46-1.06-3.91NA
Q2 2021
8/5/2021
56.13-0.66-3.83NA
Q1 2021
5/6/2021
49.59-1.18-4.20NA
Q4 2020
2/25/2021
65.13-1.01-3.80NA
Q3 2020
11/5/2020
40.99-0.98-3.41NA
Q2 2020
8/11/2020
28.39-1.03-2.94NA
Q1 2020
5/13/2020
30.78-0.78-5.37NA
Q4 2019
3/2/2020
32.21-0.62NANA
Q3 2019
11/7/2019
24.42-0.51NANA
Q2 2019
8/14/2019
25.89-3.46NANA
Quotes delayed 20 minutes

Email EnvelopeFree BBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
BridgeBio Pharma (BBIO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BBLG PE Ratio History
BCAB PE Ratio History
BCDA PE Ratio History
BCEL PE Ratio History
BCLI PE Ratio History
BCRX PE Ratio History
BDSI PE Ratio History
BDSX PE Ratio History
BDTX PE Ratio History
BDX PE Ratio History
How should the BBIO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like BridgeBio Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BBIO Historical PE Ratio page.

What is the average historical PE for BBIO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BBIO historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for BBIO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BBIO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the BridgeBio Pharma Historical PE Ratio information for BridgeBio Pharma' stock. The average BBIO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BBIO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BBIO historical PE result, against the recent PE: when this page was posted on 4/22/2024, the most recent closing price for BBIO had been 25.07, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on BBIO or any other given stock, valuation analysis for BBIO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate BridgeBio Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BBIO. Thanks for visiting, and the next time you need to research BBIO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: TD Average Annual Return, Funds Holding SCPL, RTX MACD.

 

BridgeBio Pharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.